Cargando…
Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings
The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19). Although there are ongoing clinical trials of repurposed and investigational antiviral and immune-base...
Autores principales: | Abena, Pascale M., Decloedt, Eric H., Bottieau, Emmanuel, Suleman, Fatima, Adejumo, Prisca, Sam-Agudu, Nadia A., Muyembe TamFum, Jean-Jacques, Seydi, Moussa, Eholie, Serge P., Mills, Edward J., Kallay, Oscar, Zumla, Alimuddin, Nachega, Jean B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Tropical Medicine and Hygiene
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253100/ https://www.ncbi.nlm.nih.gov/pubmed/32323646 http://dx.doi.org/10.4269/ajtmh.20-0290 |
Ejemplares similares
-
Artemisia Spp. Derivatives for COVID-19 Treatment: Anecdotal Use, Political Hype, Treatment Potential, Challenges, and Road Map to Randomized Clinical Trials
por: Kapepula, Paulin M., et al.
Publicado: (2020) -
Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo—Priorities for Achieving Control
por: Nachega, Jean B., et al.
Publicado: (2020) -
Limiting the spread of COVID-19 in Africa: one size mitigation strategies do not fit all countries
por: Mehtar, Shaheen, et al.
Publicado: (2020) -
Contact Tracing and the COVID-19 Response in Africa: Best Practices, Key Challenges, and Lessons Learned from Nigeria, Rwanda, South Africa, and Uganda
por: Nachega, Jean B., et al.
Publicado: (2021) -
The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19
por: Lee, Zelyn, et al.
Publicado: (2021)